0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  FREE
Liat Ayalon, PhD; Kenneth E. Covinsky, MD, MPH
Arch Intern Med. 2009;169(22):2156-2161. doi:10.1001/archinternmed.2009.386.

Original Investigation |  FREE
Jorge R. Kizer, MD, MSc; David A. Zisman, MD; Nancy P. Blumenthal, MSN, CRNP; et al.
Arch Intern Med. 2004;164(5):551-556. doi:10.1001/archinte.164.5.551.

Review Article |  FREE
Harold R. Collard, MD; Talmadge E. King Jr, MD
Arch Intern Med. 2003;163(1):17-29. doi:10.1001/archinte.163.1.17.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Clinical Trials Update  | 
Two Drugs Reduce Progression of Idiopathic Pulmonary Fibrosis
Anita Slomski
JAMA
Original Contribution  | 
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto, DrPH; Yingze Zhang, PhD; Tasha E. Fingerlin, PhD; et al.
JAMA
News From the Centers for Disease Control and Prevention  | 
NIOSH Warns of Nanomaterials’ Health Risks

JAMA
Capitol Health Call  | 
Black Lung Disease
Mike Mitka, MSJ